#United States #New York #Gross Law Firm #LifeMD #LFMD

LifeMD, Inc. Faces Legal Action Amid Securities Law Violations

In a significant legal development, LifeMD, Inc. (NASDAQ: LFMD) is currently under fire due to allegations of securities law violations. The Gross Law Firm recently released a notice urging shareholders who purchased shares during the class period from May 7, 2025, to August 5, 2025, to contact them promptly. This advisory emphasizes the importance of understanding shareholder rights and the legal ramifications stemming from the company's business practices.

Allegations Against LifeMD

The complaint against LifeMD outlines several key allegations that put the company's credibility into question. It claims that during the specified class period, the defendants made materially false statements or failed to disclose crucial information resulting in misleading guidance to investors. One major claim is that LifeMD overstated its competitive position and failed to adequately consider rising customer acquisition costs, particularly in its RexMD segment and associated with drugs like Wegovy and Zepbound intended to treat obesity. As a result, the accusations suggest that statements from the company's management regarding its business operations and overall prospects were fundamentally flawed.

These serious allegations have implications not just for the company management but also for the investors who may have purchased shares based on this misleading information. The Gross Law Firm has recognized the importance of supporting investors during such troubling times, advocating for those who have felt the impact of these claims.

Next Steps for Shareholders

The Gross Law Firm emphasizes that all shareholders who bought shares of LifeMD during the aforementioned class period should not delay in registering for this class action. Investors are encouraged to register their information on the firm's website and additionally take steps to join the action before the approaching deadline of October 27, 2025. By registering, shareholders will also be enrolled in a portfolio monitoring service, providing ongoing updates about the status of the case, which enhances transparency and communication throughout this process.

It's worth noting that registering as a lead plaintiff is optional for participation in the recovery process, which means shareholders can still be involved without the added responsibilities of a lead position.

Why Choose The Gross Law Firm?

The Gross Law Firm stands out in the realm of class action lawsuits, as it possesses a reputable track record in protecting investor rights against fraudulent and deceitful practices in corporate environments. Their mission is grounded in accountability, striving to ensure companies maintain responsible and ethical business standards. With a focus on securing recovery for investors who faced losses due to misleading statements or omissions of key information that led to stock price inflation, the Gross Law Firm aims to uphold investor integrity and provide justice in the financial arena.

For LifeMD shareholders, awareness of these allegations and the recent legal actions is critical. As the situation continues to unfold, staying informed and involved will be paramount in safeguarding their financial interests.

Contact Information

For more information and to register, affected shareholders can reach out to The Gross Law Firm directly:

• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

As breach of investor trust poses significant ramifications, timely action from shareholders will be crucial in navigating the implications of such legal challenges.